1-(3-(2-Chloroethyl)-3-nitrosoureido)cyclopentanecarboxylic acid ethyl ester

Suppliers

Names

[ CAS No. ]:
13909-05-2

[ Name ]:
1-(3-(2-Chloroethyl)-3-nitrosoureido)cyclopentanecarboxylic acid ethyl ester

[Synonym ]:
1-({[(2-chloroethyl)nitrosoamino]carbonyl}amino)-cyclopentanecarboxylic acid,ethyl ester
Cyclopentanecarboxylic acid,1-(3-(2-chloroethyl)-3-nitrosoureido)-,ethyl ester
1-(3-(2-Chloroethyl)-3-nitrosoureido)cyclopentanecarboxylic acid ethyl ester
Cyclopentanecarboxylic acid,1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-,ethyl ester
ethyl 1-{[(2-chloroethyl)(nitroso)carbamoyl]amino}cyclopentanecarboxylate

Chemical & Physical Properties

[ Density]:
1.36g/cm3

[ Molecular Formula ]:
C11H18ClN3O4

[ Molecular Weight ]:
291.73100

[ Exact Mass ]:
291.09900

[ PSA ]:
88.07000

[ LogP ]:
2.18500

[ Index of Refraction ]:
1.565

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
GY2628000
CHEMICAL NAME :
Cyclopentanecarboxylic acid, 1-(3-(2-chloroethyl)-3-nitrosoureido)-, ethyl ester
CAS REGISTRY NUMBER :
13909-05-2
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C11-H18-Cl-N3-O4
MOLECULAR WEIGHT :
291.77
WISWESSER LINE NOTATION :
L5TJ AVO2 AMVNNO&2G

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. (Bethesda, MD 20205) Volume(issue)/page/year: JAN1986

Precursor & DownStream

Precursor

  • Cyclopentanecarboxylicacid, 1-amino-, ethyl ester
  • ethyl 1-(2-chloroethylcarbamoylamino)cyclopentane-1-carboxylate

DownStream

Related Compounds

  • 4-[(10aS)-7,8-dimethoxy-1,3-dioxo-1,5,10,10a-tetrahydroimidazo[1,5-b]isoquinolin-2(3H)-yl]-N-(2,2-dimethoxyethyl)butanamide
  • (Z)-8-(2-methoxybenzyl)-2-(2,3,4-trimethoxybenzylidene)-8,9-dihydro-2H-benzofuro[7,6-e][1,3]oxazin-3(7H)-one
  • N-[4,5-dimethyl-3-(phenylsulfonyl)-1-(propan-2-yl)-1H-pyrrol-2-yl]-4-fluorobenzamide
  • (2Z)-8-(3,4-dimethoxybenzyl)-2-(pyridin-4-ylmethylidene)-8,9-dihydro-7H-furo[2,3-f][1,3]benzoxazin-3(2H)-one
  • (4,6-dimethoxy-1-methyl-1H-indol-2-yl)(1H-imidazol-1-yl)methanone
  • 5-phenyl-4-[2-(1-pyrrolidinyl)ethyl]-4H-1,2,4-triazol-3-yl hydrosulfide
  • 2-Chlorophenyl [3-(2-quinolinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl]methyl ether
  • 3-(3,4-dimethoxyphenyl)-9-(4-methoxybenzyl)-9,10-dihydro-2H,8H-chromeno[8,7-e][1,3]oxazin-2-one
  • N-{1-(2-methoxyethyl)-4,5-dimethyl-3-[(4-methylphenyl)sulfonyl]-1H-pyrrol-2-yl}cyclohexanecarboxamide
  • N-[2-(2,5-dimethoxybenzoyl)-3-methyl-1-benzofuran-6-yl]pyridine-4-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.